Catherine Abi-Habib - Global
Skip to main content
Ipsen Home Page
Press shift tab to select search category

Loading...
  • Media  arrow down
    < Back
    • Press Releases
    • Media Statements
    • Media Library
    • Our 2023 Integrated Annual Report is live!

      Featured Image
  • Investors arrow down
      < Back
    • Investors
    • Investors
    • Financial Results
    • Annual Reports and Accounts
    • Presentations
    • Corporate News
    • Financial Calendar
    • Investor Events
    • Shareholder Information
    • Share-Price Data
    • Regulated Information
    • Key Contacts
  • Partnering
  • Careers arrow down
      < Back
    • Careers
    • Careers – 2
    • Working at Ipsen
    • Culture
  • Press shift tab to select search category

    Loading...
  • English  EN     Français  FR     EN  arrow_down
    • English EN
    • Français FR
  • Global Global
    < Back
    • Global EN FR
    • Annual Report EN FR
    • Americas
    • Asia Pacific
    • Europe
    • Middle East & Africa
    • United States
    • Brazil
    • Canada
    • Mexico
    • Australia
    • China
    • Singapore
    • South Korea
    • Japan
    • Belgium
    • Ukraine
    • UK
    • Germany
    • France
    • Nordics
    • Greece
    • Italy
    • Netherlands
    • Spain
    • Poland
    • Russia
    • Czech Republic
    • Austria
    • Switzerland
    • UAE & Gulf
  • Home
  • Company
      < Back
    • Company
    • Company
    • Leadership
        < Back
      • Company
      • History
      • Fondation Ipsen
  • Science
      < Back
    • Science
    • Science
    • Oncology
    • Rare Disease
    • Neuroscience
    • Products
    • R&D
        < Back
      • Science
      • Pipeline
    • Clinical Trials
  • Responsibility
      < Back
    • Responsibility
    • Responsibility
    • Environment
    • Patients
    • People
    • Governance
    • Our Standards
  • Patients
      < Back
    • Patients
    • Patients
    • Together for Oncology
    • Together for Rare Disease
    • Together for Neuroscience
    • Lay Summaries
    • Collaborate with us
  • Stories
  • New Home Page
  1. Home
  2. Company
  3. Leadership Team
  4. leadership

Catherine Abi-Habib

Back
Catherine Abi-Habib

Catherine Abi-Habib

  • Executive Vice President,
  • Strategy, Transformation and Digital
  • Follow in LinkedIn

Catherine Abi-Habib joined Ipsen in 2022 as Executive Vice President, Strategy, Transformation and Digital.

Prior to joining Ipsen, Catherine spent more than 10 years working with pharmaceutical and biotech companies, health systems, payors, providers, and charitable foundations. She joined Ipsen from McKinsey, where she was a Partner in the Life Sciences practice based in London. Working closely with QuantumBlack, McKinsey’s advanced analytics firm, she partnered with leading biopharma companies on large-scale digital and analytics driven transformations across North America, Europe and Asia, focused on improving physician experience.

Catherine holds an MSc. in Economics from the London School of Economics and a BA in Mathematics from the University of Cambridge, Trinity College.

Related stories

Ipsen’s partnership with Marengo
02 June 2023 0 mins read

Ipsen’s partnership with Marengo

Ipsen’s 2022 Integrated Annual Report now available
01 June 2023 1 mins read

Ipsen’s 2022 Integrated Annual Report now available

Rethinking risk factors this Liver Cancer Awareness Month
02 March 2023 1 mins read

Rethinking risk factors this Liver Cancer Awareness Month

Ipsen FY/Q4 2022 results–A word from CEO David Loew
09 February 2023 1 mins read

Ipsen FY/Q4 2022 results–A word from CEO David Loew

Related assets

Executive leadership team – Sandra Silvestri

Executive leadership team – Sandra Silvestri

Executive leadership team – Howard Mayer

Executive leadership team – Howard Mayer

IPN price

€103.00

 €-0.70 (-0.68%)

  • Terms and Conditions
  • Cookie Policy
  • Global Privacy Policy
  • Company
  • Responsibility
  • Patients
  • Stories
  • Annual Report
  • Contact us

Ipsen logo
LinkedIn Instagram Facebook Youtube
  • Terms and Conditions
  • Cookie Policy
  • Global Privacy Policy

Copyright © Ipsen Pharma. All rights reserved - 2024

You are now leaving the Ipsen group website.
To continue, please click on Continue?

Continue
This site is registered on wpml.org as a development site. Switch to a production site key to remove this banner.